Jason Cohen

About the Author Jason Cohen

Jason is a Smarter Analyst editor and writer, who specializes in biotech and cannabis-based pharmaceutical companies.

MLV Assigns Buy On Compugen Shares, Sees 86% Upside

MLV analyst George Zavoico assigned a Buy rating on Compugen (NASDAQ:CGEN) with a price target of $14.00, which represents a potential upside of …

Deutsche Bank Upgrades Acadia Healthcare Shares To Buy, Sees 11% Upside

In a research report issued today, Deutsche Bank analyst Darren Lehrich upgraded shares of Acadia Healthcare (NASDAQ:ACHC) to Buy from Hold and raised his …

Roth Capital Assigns Buy On Shares Of Verastem, $29 PT

Roth Capital analyst Joseph Pantginis assigned a Buy rating on Verastem (NASDAQ:VSTM) with a $29 price target, which represents a potential upside of 188% …

Roth Capital Reiterates Buy On Gentherm, Sees 28% Upside For The Stock

In a research report issued today, Roth Capital analyst Matt Koranda reiterated a Buy rating on Gentherm Inc (NASDAQ:THRM) with a price target …

Roth Capital Reiterates Buy On Inventure Foods Shares, $15 PT

In a research report issued today, Roth Capital analyst Anton Brenner reiterated a Buy rating on Inventure Foods (NASDAQ:SNAK) with a price target …

Roth Capital Reiterates Buy On Manitex International; Sees 50% Upside For The Stock

Roth Capital analyst Matt Koranda reiterated a Buy rating on Manitex International (NASDAQ:MNTX) with a price target of $17.00, which represents a potential …

Roth Capital Reiterates Buy On The Middleby Shares, $115 PT

In a research report published today, Roth Capital analyst Anton Brenner reiterated a Buy rating on The Middleby (NASDAQ:MIDD) with a price target of …

Roth Capital Assigns Buy On Attunity Ltd Shares, Sees 62% Upside For The Stock

Roth Capital analyst Richard Baldry assigned a Buy rating on Attunity Ltd (NASDAQ:ATTU) with a price target of $13.50, which represents a potential …

MLV Upgrades Genesis Energy Shares To Buy, Sees 29% Upside For The Stock

In a research report issued today, MLV analyst Daniel Schenk reiterated a Buy rating on Genesis Energy (NYSE:GEL) with a price target of $60, which …

MLV Maintains Hold On Shares Of Aviv REIT, Sees 11% Downside For The Stock

In a research report issued today, MLV analyst Paul Morgan maintained a Hold rating on Aviv REIT, Inc. (NYSE:AVIV) with a price target of …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts